ID   64CP
AC   CVCL_1B36
SY   833K(64CP)
DR   Wikidata; Q54604390
RX   CelloPub=CLPUB00240;
RX   PubMed=9772905;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2292 ! 833K-E
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
RX   CelloPub=CLPUB00240;
RA   Roth B.J., Sledge G.W. Jr., Heerema N.A., Schultz S.M.;
RT   "Establishment and initial characterization of a human testicular
RT   cancer cell line with acquired resistance to cis-diaminedichloroplatinum.";
RL   Proc. Am. Assoc. Cancer Res. 30:526A.2094-526A.2094(1989).
//
RX   PubMed=9772905; DOI=10.1016/S0165-4608(98)00042-9;
RA   Blough R.I., Vance G.H., Henegariu O., Smolarek T.A., Sledge G.W. Jr.,
RA   Heerema N.A.;
RT   "Characterization of multiple 12p rearrangements in testicular germ
RT   cell tumor cell line 833K and its subclone 64CP by chromosome
RT   microdissection.";
RL   Cancer Genet. Cytogenet. 106:24-29(1998).
//